Strategic vaccination responses to Chikungunya outbreaks in Urban Europe
2024

Vaccination Strategies for Chikungunya Outbreaks in Rome

Sample size: 2749030 publication 10 minutes Evidence: high

Author Information

Author(s): Sloof Albertus Constantijn, Boer Martijn, Vondeling Gerard T., de Roo Adrianne M., Jaramillo Juan Carlos, Postma Maarten J.

Primary Institution: Department of Health Sciences, University Medical Center Groningen, Groningen, Netherlands

Hypothesis

Can emergency vaccination effectively reduce the impact of a chikungunya outbreak in Rome?

Conclusion

Timely vaccination interventions can significantly decrease the spread of chikungunya virus during outbreaks.

Supporting Evidence

  • Without vaccination, an outbreak could infect up to 6.21% of Rome’s population.
  • Emergency vaccination at 40% coverage could prevent 139,805 cases.
  • Even at 10% coverage, significant benefits are observed with a 33% reduction in infections.
  • Vaccination can flatten the epidemic curve and reduce the burden of disease.
  • Timely vaccination is crucial for managing emerging infectious diseases.

Takeaway

If a lot of people get a shot quickly, we can stop a sickness called chikungunya from spreading too much.

Methodology

A dynamic SEIR model was used to simulate the transmission of chikungunya virus among humans and mosquitoes.

Potential Biases

Potential bias due to reliance on assumptions about population density and mosquito behavior.

Limitations

The model assumes homogeneous mixing of populations and relies on limited data for some parameters.

Participant Demographics

The study focused on the urban population of Rome, Italy.

Statistical Information

P-Value

0.001

Confidence Interval

95% CI: 7.1–14

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0012713

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication